Brachyury expression in extra-axial skeletal and soft tissue chordomas: A marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue

American Journal of Surgical Pathology

Volumn 32, Issue 4, 2008, Pages 572-580

  Tirabosco, Roberto ^a   Mangham, D Chas ^b,c   Rosenberg, Andrew E ^f   Vujovic, Sonja ^a   Bousdras, Konstantinos ^d   Pizzolitto, Stefano ^h   De Maglio, Giovanna ^h   Den Bakker, Michael A ⁱ   Di Francesco, Lisa ^j   Kalil, Ricardo K ^k   Athanasou, Nicholas A ^e   O'Donnell, Paul ^a   McCarthy, Edward F ^g   Flanagan, Adrienne M ^a,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^c ROBERT JONES AND AGNES HUNT ORTHOPAEDIC HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^e NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g JOHNS HOPKINS HOSPITAL   (United States)

^h SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

ⁱ ERASMUS MEDICAL CENTER   (Netherlands)

^j UNIVERSITY OF CALGARY   (Canada)

^k SARAH NETWORK OF REHABILITATION HOSPITALS   (Brazil)

more..

Author keywords

Brachyury; Chordoma; Extra axial chordoma; Mixed tumor; Parachordoma

Indexed keywords

BRACHYURY PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE TUMOR; CHORDOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GERM CELL; HEMANGIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MYOEPITHELIOMA; PROTEIN EXPRESSION; SOFT TISSUE TUMOR; SPERMATOGONIUM; TUMOR RECURRENCE;

ADULT; AGED; BONE NEOPLASMS; CHORDOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FETAL PROTEINS; HEMANGIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MIXED TUMOR, MALIGNANT; MYOEPITHELIOMA; NEOPLASMS, GERM CELL AND EMBRYONAL; POSITRON-EMISSION TOMOGRAPHY; RECURRENCE; SOFT TISSUE NEOPLASMS; SPERMATOGONIA; T-BOX DOMAIN PROTEINS; TESTICULAR NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 41549159470     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31815b693a     Document Type: Article

References (50)

1. Al-Adnani M, Cannon SR, Flanagan AM. Chordomas do not express CD10 or renal cell carcinoma (RCC) antigen: an immunohistochemical study. Histopathology. 2005;47:536-537.
2. Antonescu CR, Argani P, Erlandson RA, et al. Skeletal and extra-skeletal myxoid chondrosarcoma. A comparative clinicopathologic, ultrastructural, and molecular study. Cancer. 1998;83:1504-1521.
3. Ashwood N, Hoskin PJ, Saunders MI. Metastatic chordoma: pattern of spread and response to chemotherapy. Clin Oncol. 1994;6:341-342.
4. Baba S, Heike T, Umeda K, et al. Generation of cardiac and endothelial cells from neonatal mouse-derived multipotential germline stem cells. Stem Cells. 2007:1066-5099. Doi: 10.1634/stemcells.2006-0574.
5. Badwal S, Pal L, Basu A, et al. Multiple synchronous spinal extraosseous intradural chordomas: is it a distinct entity? Br J Neurosurg. 2006;20:99-103.
6. Bergh P, Kindblom LG, Gunterberg B, et al. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients. Cancer. 2000;88:2122-2134.
7. Dabska M. Parachordoma. A new clinicopathologic entity. Cancer. 1977;40:1586-1592.
8. de Pinieux G, Beabout JW, Unni KK, et al. Primary mixed tumor of bone. Skeletal Radiol. 2001;30:534-536.
9. DiFrancesco LM, Davanzo Castillo CA, Temple WJ. Extra-axial chordoma. Arch Pathol Lab Med. 2006;130:1871-1874.
10. Fisher C. Parachordoma exists - but what is it? Adv Anat Pathol. 2000;7:141-148.
11. Fisher C, Miettinen M. Parachordoma: a clinicopathologic and immunohistochemical study of four cases of an unusual soft tissue neoplasm. Ann Diagn Pathol. 1997;1:3-10.
12. Folpe AL, Agoff SN, Willis J, et al. Parachordoma is immunohistochemically and cytogenetically distinct from axial chordoma and extraskeletal myxoid chondrosarcoma. Am J Surg Pathol. 1999;23: 1059-1067.
13. Glasker S, Li J, Xia JB, et al. Hemangioblastomas share protein expression with embryonal hemangioblast progenitor cell. Cancer Res. 2006;66:4167-4172.
14. Heffelfinger MJ, Dahlin DC, MacCarthy CS, et al. Chordomas and cartilaginous tumours at the skull base. Cancer. 1973;32:410-420.
15. Heikinheimo K, Persson S, Kindblom LG, et al. Expression of different cytokeratin subclasses in human chordoma. J Pathol. 1991;164:145-150.
16. Hemalatha AL, Srinivasa MR, Parshwanath HA. Parachordoma of tibia - a case report. Indian J Pathol Microbiol. 2003;46:454.
17. Henderson SR, Guiliano D, Presneau N, et al. A molecular map of mesenchymal tumors. Genome Biol. 2005;6:R76.
18. Hermann G, Moss D, Norton KI, et al. Case report 450. Skeletal Radiol. 1987;16:657-659.
19. Hornick JL, Fletcher CDM. Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters. Am J Surg Pathol. 2002;27:1183-1196.
20. Kilpatrick SE, Hitchcock MG, Kraus MD, et al. Mixed tumours and myoepithelial tumours of soft tissue, a clinicopathological study of 19 cases with a unifying concept. Am J Surg Pathol. 1997;21: 13-22.
21. Kilpatrick SE, Limon J. Mixed tumour/myoepithelium/parachordoma. In: Fletcher CD, Unni KK, Mertens F, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumour of Soft Tissue and Bone. Lyon, France: IARC Press; 2002:198-199.
22. Koh JS, Chung JH, Lee SY, et al. Parachordoma of the tibia: report of a rare case. Pathol Res Pract. 2000;196:269-273.
23. Laskowski J. Pathology of tumors. In: Kolodziejska H, ed. Zarys Onkologii. Warsaw: PZWL; 1955:91-99.
24. Machen SK, Easley KA, Goldblum JR. Synovial sarcoma of the extremities: a clinicopathologic study of 34 cases, including semiquantitative analysis of spindled, epithelial, and poorly differentiated areas. Am J Surg Pathol. 1999;23:268-275.
25. McMaster ML, Goldstein AM, Bromley CM, et al. Chordoma: incidence and survival patterns in the United States, 1973-1995. Cancer Causes Control. 2001;12:1-11.
26. McPherson CM, Suk K, McCutcheon IE, et al. Metastatic disease from spinal chordomas: a 10 year experience. J Neurosurg Spine. 2006;5:277-280.
27. Mirra JM, Della Rocca C, Nelson SD, et al. Chordoma. In: Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of Soft tissue and Bone. Lyon: IARC Press; 2002:316-317.
28. Nielsen GP, Mangham DC, Grimer RJ, et al. Chordoma periphericum: a case report. Am J Surg Pathol. 2001;25:263-267.
29. O'Donnell P, Tirabosco R, Vujovic S, et al. Diagnosing an extra-axial chordoma of the proximal tibia with the help of brachyury, a molecule required for notochordal differentiation. Skeletal Radiol. 2006;36:59-65.
30. O'Hara BJ, Paetau A, Miettinen M. Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma. Hum Pathol. 1998;29:119-126.
31. Oliveira AM, Sebo TJ, McGrory JE, et al. Extraskeletal myxoid chondrosarcoma: a clinicopathologic, immunohistochemical, and ploidy analysis of 23 cases. Mod Pathol. 2000;13:900-908.
32. Palena C, Polev DE, Tsang KY, et al. The human T-box mesodermal transcription factor brachyury is a candidate target for T-cell-mediated cancer immunotherapy. Clin Cancer Res. 2007;13:2471-2478.
33. Park DM, Zhuang Z, Chen L, et al. von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells. PLos Med. 2007;4:e60.
34. Pazzaglia UE, Salisbury JR, Byers PD. Development and involution of the notochord in the human spine. J R Soc Med. 1989;82:413-415.
35. Povysil C, Matejovsky Z. A comparative ultrastructural study of chondrosarcoma, chordoid sarcoma, chordoma and chordoma periphericum. Pathol Res Pract. 1985;179:546-559.
36. Qureshi AA, Gitelis S, Templeton AA, et al. "Benign" metastasizing pleomorphic adenoma. A case report and review of literature. Clin Ortho Rel Res. 1994;308:192-198.
37. Romeo S, Hogendoorn PCW. Brachyury and chordoma: the chondroid-chordoid dilemma resolved? J Pathol. 2006;209:143-146.
38. Rosenberg AE, Brown GA, Bhan AK, et al. Chondroid chordoma: a variant of chordoma. Anat Pathol. 1994;101:36-41.
39. Salisbury JR. The pathology of the notochord: review article. J Pathol. 1993;171:153-155.
40. Salisbury JR, Isaacson PG. Demonstration of cytokeratin and an epithelial membrane antigen in chordomas and human fetal notochord. Am J Surg Pathol. 1985;9:791-797.
41. Schofield JB, Krausz T, Stamp GW, et al. Ossifying fibromyxoid tumour of soft parts: immunohistochemical and ultrastructural analysis. Histopathology. 1993;22:101-112.
42. Scolyer RA, Bonar SF, Palmer AA, et al. Parachordoma is not distinguishable from axial chordoma using immunohistochemistry. Pathol Int. 2004;54:364-370.
43. Showell C, Binder O, Conlon FL. T-box genes in early embryogenesis. A review. Dev Dyn. 2004;229:202-218.
44. Spivach A, Zanconati F, Tirabosco R, et al. Parachordoma of the gastric serosa: report of a myxoid mimicry in an unusual location. Int J Surg Pathol. 2007;15:307-310.
45. Sundaresan N, Galicich JH, Chu FC, et al. Spinal chordomas. J Neurosurg. 1979;50:312-319.
46. van Akkooi AC, van Geel AN, Bessems JH, et al. Extra-axial chordoma. J Bone Jt Surg (Br). 2006;88:1232-1234.
47. Vujovic S, Henderson SR, Presneau N, et al. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol. 2006;209:157-165.
48. Watson JAS, Walker MM, Smith NP, et al. Malignant chondroid syringoma - a rare cause of secondary bone tumour. Clin Exp Dermatol. 1991;16:306-307.
49. Yamaguchi T, Suzuki S, Ishiiwa H, et al. Intraosseous benign notochordal cell tumours: overlooked precursors of classical chordomas? Histopathology. 2003;44:597-602.
50. Yamaguchi T, Suzuki S, Ishiiwa H, et al. Benign notochordal cell tumors: a comparative histological study of benign notochordal cell tumors, classic chordomas, and notochordal vestiges of fetal intervertebral discs. Am J Surg Pathol. 2004;28:756-762.